|
ZNF738 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.714300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.290200E-02 |
| Normal-vs-Stage2 |
1.239760E-01 |
| Normal-vs-Stage3 |
4.374200E-02 |
| Normal-vs-Stage4 |
4.782200E-01 |
| Stage1-vs-Stage2 |
6.227800E-01 |
| Stage1-vs-Stage3 |
9.217600E-01 |
| Stage1-vs-Stage4 |
2.171800E-01 |
| Stage2-vs-Stage3 |
6.166200E-01 |
| Stage2-vs-Stage4 |
4.409600E-01 |
| Stage3-vs-Stage4 |
2.149600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.617700E-02 |
| Normal-vs-AfricanAmerican |
9.071400E-01 |
| Normal-vs-Asian |
4.211200E-01 |
| Caucasian-vs-AfricanAmerican |
1.292630E-01 |
| Caucasian-vs-Asian |
2.304400E-02 |
| AfricanAmerican-vs-Asian |
3.201800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.059500E-02 |
| Normal-vs-Female |
3.087000E-01 |
| Male-vs-Female |
4.248400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.767000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.001170E-01 |
| Normal-vs-Age(61-80Yrs) |
1.964220E-02 |
| Normal-vs-Age(81-100Yrs) |
8.901100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.564000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.402100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.383600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.470640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.366620E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.129600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.281000E-01 |
| Normal-vs-Grade 2 |
8.490200E-02 |
| Normal-vs-Grade 3 |
1.796390E-02 |
| Normal-vs-Grade 4 |
2.929000E-01 |
| Grade 1-vs-Grade 2 |
1.331920E-02 |
| Grade 1-vs-Grade 3 |
3.878000E-02 |
| Grade 1-vs-Grade 4 |
1.311430E-01 |
| Grade 2-vs-Grade 3 |
2.193800E-01 |
| Grade 2-vs-Grade 4 |
6.211800E-01 |
| Grade 3-vs-Grade 4 |
2.290200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.756100E-03 |
| Normal-vs-ccB subtype |
2.314000E-01 |
| ccA subtype-vs-ccB subtype |
3.038000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.414300E-02 |
| Normal-vs-N1 |
7.076000E-01 |
| N0-vs-N1 |
2.927800E-01 |
|
|
